Stay updated on T-VEC + Pembrolizumab in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.

Latest updates to the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new document revision tag v3.6.3 has been added. The previous revision v3.6.0 has been removed, indicating an administrative update to the study materials.SummaryDifference0.1%

- Check34 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', affecting who can join or monitor the trial. New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the revision note updated to v3.6.0, with the 'Intervention / Treatment' formatting and the older 'Revision: v3.5.5' note removed.SummaryDifference0.4%

- Check42 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5. This indicates a new version of the document rather than substantive content changes.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page now shows an updated study protocol revision: v3.5.4, replacing the previous revision v3.5.3. This reflects an updated version of the study-related documents linked to the trial.SummaryDifference0.1%

- Check85 days agoChange DetectedClinicalTrials.gov’s page footer revision tag was updated from v3.5.2 to v3.5.3, indicating a site/version update without changing the study details.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision: v3.5.2 is now shown, replacing the previous Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to T-VEC + Pembrolizumab in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-VEC + Pembrolizumab in Sarcoma Clinical Trial page.